Correlation between plasma HIV-1 RNA levels and the rate of immunologic decline

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 14, Issue 5, 1997, Pages 408-414

  Iuliano, Rodolfo ^a   Forastieri, Giuseppe ^a   Brizzi, Mauro ^b   Mecocci, Lorenzo ^b   Mazzotta, Francesco ^b   Ceccherini Nelli, Luca ^a,c  

^a UNIVERSITY OF PISA   (Italy)

^b SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

branched DNA signal amplification; CD4+ cells; Human immunodeficiency virus type 1; p24 antigenemia; plasma viral load quantitation; 2 microglobulin

Indexed keywords

ANTIGEN P24; ANTIRETROVIRUS AGENT; BETA 2 MICROGLOBULIN; CD4 ANTIGEN; DIDANOSINE; DNA; STAVUDINE; VIRUS RNA; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MULTICENTER STUDY; PLASMA; PRIORITY JOURNAL; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030974060     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199704150-00003     Document Type: Article

References (33)

1. Paul DA, Falk LA, Kessler HA, et al. Correlation of serum HIV antigen and antibody with clinical status in HIV-infected patients. J Med Virol 1987;22:357-63.
2. Ho DD, Moudgil T, Alam M. Quantitation of human immunodeficiency virus type in the blood of infected persons. N Engl J Med 1989;321:1621-5.
3. Coombs RW, Collier AC, Allain JP, et al. Plasma viremia in human immunodeficiency virus infection. N Engl J Med 1989;321: 1626-31.
4. Michael NL, Vahey M, Burke DS, Redfield RR. Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease. J Virol 1992;66:310-6.
5. Bagnarelli P, Menzo S, Valenza A, et al. Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS. J Virol 1992;66:7328-35.
6. Pantaleo G, Graziosi C, Demarest JF, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993;362:355-8.
7. Piatak M Jr, Saag MS, Yang LC, et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993;259:1749-54.
8. + lymphocytes. Proc Natl Acad Sci USA 1994;91:1104-8.
9. Wei X, Ghosh SK, Taylor MA, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117-22.
10. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-6.
11. Mellors JW, Kingsley LA, Rinaldo CR, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995;122:573-9.
12. Cohen OJ, Pantaleo G, Holodniy M, et al. Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissue. Proc Natl Acad Sci U S A 1995;92:6017-21.
13. Reddy MM, Winger EE, Hargrove D, McHugh T, McKinley GF, Grieco MH. An improved method for monitoring efficacy of antiretroviral therapy in HIV-infected individuals: a highly sensitive HIV p24 antigen assay. J Clin Lab Anal 1992;6:125-9.
14. Dewar RL, Highbarger HC, Sarmiento MD, et al. Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J Infect Dis 1994; 170:1172-9.
15. Cao Y, Ho DD, Todd J, et al. Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma. AIDS Res Hum Retroviruses 1995;11:353-61.
16. Menzo S, Bagnarelli P, Giacca M, Manzin A, Varaldo PE, Clementi M. Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction. J Clin Microbiol 1992;30:1752-7.
17. Semple M, Loveday C, Weller I, Tedder R. Direct measurement of viraemia in patients infected with HIV-1 and its relationship to disease progression and zidovudine therapy. J Med Virol 1991;35: 38-45.
18. Pachl C, Todd JA, Kern DG, et al. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8:446-54.
19. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA 1993; 269:729-30.
20. Henrard DR, Phillips JF, Muenz LR, et al. Natural history of HIV-1 cell-free viremia. JAMA 1995;274:554-8.
21. Hogevorst E, Jurriaans S, de Wolf F, et al. Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels. J Infect Dis 1995;171:811-21.
22. Katzenstein TL, Pedersen C, Nielsen C, Lundgren JD, Jakobsen PH, Gerstoft J. Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome. AIDS 1996;10:167-73.
23. Bailey NTJ. Statistical methods in biology. Boston: Hodder & Stoughton, 1981.
24. Coffin JM. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 1995;267: 483-9.
25. Embretson J, Zupancic M, Ribas JL, et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993;362:359-62.
26. Weber J, Ariyoshi K. Lack of correlation between acidified HIV p24 antigen and plasma viremia. AIDS 1992;6:428-9.
27. O'Shea S, Rostron T, Hamblin AS, Palmer SJ, Banatvala JE. Quantitation of HIV: correlation with clinical, virological, and immunological status. J Med Virol 1991;35:65-9.
28. Lafeuillade A, Tamalet C, Pellegrino P, De Micco P, Vignoli C, Quilichini R. Correlation between surrogate markers, viral load, and disease progression in HIV-1 infection. J Acquir Immune Defic Syndr 1994;7:1028-33.
29. 2 microglobulin level increases in HIV infection: relation to seroconversion, CD4 T cell fall and prognosis. AIDS 1990;4:207-14.
30. Lifson AR, Hessol NA, Buchbinder SP, et al. Serum beta-2-microglobulin and prediction of progression to AIDS in HIV infection. Lancet 1992;339:1436-40.
31. Holodniy M, Katzenstein DA, Israelski DM, Merigan TC. Diurnal and short term stability of HIV virus load as measured by gene amplification. J Acquir Immune Defic Syndr 1994;7:363-8.
32. Mellors JW, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70.
33. Haynes BF, Pantaleo G, Fauci AS. Toward an understanding of the correlates of protective immunity to HIV infection. Science 1996; 271:324-8.